Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Falling Comet
903.7000 17.30 (1.95%)
NSE Mar 25, 2026 15:31 PM
Volume: 574.3K
 

logo
Zydus Lifesciences Ltd.
21 Nov 2019
903.70
1.95%
Business Line
Cadila Healthcare said it has received approval from the US health regulator to market Isosorbide Dinitrate tablets used to prevent attacks of chest p
Zydus Lifesciences Ltd. is trading below its 30 day SMA of 904.9
USFDA approves Zydus Cadila's Dinitrate tablets, Desonide Cream
Business Line | 21 Nov 2019 1 more
More from Zydus Lifesciences Ltd.
Recommended
Between Swiggy and Zomato, Swiggy takes the dark patterns crown
The Baseline | 25 Mar 2026, 06:40PM
Market closes higher as the US seeks a month-long ceasefire in the Iran war
Trendlyne Marketwatch | 25 Mar 2026, 04:12PM
Earnings Call Transcript - Cadila Healthcare
| 14 Feb 2020